GSK PLC Stock Performance and Recent Developments
GSK PLC, a leading pharmaceutical company listed on the London Stock Exchange, has experienced fluctuations in its stock price over the past few years. The company’s stock price has ranged from a 52-week high of £1,678.68 to a low of £1,242.50.
Historical Stock Price Performance
- 52-week high: £1,678.68
- 52-week low: £1,242.50
- 5-year stock price performance:
- Initial investment price: £20.41
- Current stock price: £14.06
- Change in stock price: -31.1%
Recent Company Developments
GSK has received positive news in the form of FDA approval for its Benlysta autoinjector for lupus treatment. Additionally, the company has rebranded its Flovent asthma inhaler for children to avoid a Medicaid rebate, which could have a positive impact on the company’s finances.
Analyst Recommendations
- Analysts have issued mixed recommendations for GSK, with some raising their price targets and others placing the company on “negative catalyst watch.”
Market Performance
The FTSE 100 index, which includes GSK PLC as one of its constituents, has started the week on a positive note. The index rose 0.19% to £8,815.79 on the first day of trading.